Clifford Capital Partners LLC Has $14.96 Million Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Clifford Capital Partners LLC reduced its stake in Cardinal Health, Inc. (NYSE:CAHFree Report) by 3.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 135,314 shares of the company’s stock after selling 4,713 shares during the quarter. Cardinal Health comprises 3.0% of Clifford Capital Partners LLC’s holdings, making the stock its 21st largest holding. Clifford Capital Partners LLC owned about 0.06% of Cardinal Health worth $14,955,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Paragon Capital Management Inc. grew its holdings in Cardinal Health by 0.7% during the second quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company’s stock worth $1,451,000 after buying an additional 99 shares in the last quarter. Aptus Capital Advisors LLC grew its holdings in Cardinal Health by 5.1% during the second quarter. Aptus Capital Advisors LLC now owns 2,071 shares of the company’s stock worth $204,000 after buying an additional 100 shares in the last quarter. Midland Wealth Advisors LLC boosted its position in Cardinal Health by 4.2% in the second quarter. Midland Wealth Advisors LLC now owns 2,488 shares of the company’s stock worth $245,000 after purchasing an additional 100 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its position in Cardinal Health by 0.5% in the second quarter. Oregon Public Employees Retirement Fund now owns 20,891 shares of the company’s stock worth $2,054,000 after purchasing an additional 100 shares during the last quarter. Finally, Huntington National Bank boosted its position in Cardinal Health by 0.9% in the third quarter. Huntington National Bank now owns 10,792 shares of the company’s stock worth $1,193,000 after purchasing an additional 100 shares during the last quarter. 87.17% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have weighed in on CAH shares. Wells Fargo & Company boosted their price objective on Cardinal Health from $95.00 to $101.00 and gave the stock an “underweight” rating in a research report on Thursday, August 15th. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd. Evercore ISI upped their price target on Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a research report on Thursday, August 15th. Morgan Stanley upped their price target on Cardinal Health from $119.00 to $127.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the stock. According to MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus price target of $123.00.

Read Our Latest Research Report on CAH

Cardinal Health Stock Performance

NYSE:CAH opened at $122.45 on Wednesday. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $126.14. The firm has a market cap of $29.63 billion, a price-to-earnings ratio of 23.82, a PEG ratio of 1.52 and a beta of 0.60. The business’s fifty day moving average is $114.07 and its 200 day moving average is $106.13.

Cardinal Health (NYSE:CAHGet Free Report) last released its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. The company had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The firm’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period in the previous year, the company posted $1.73 EPS. Equities analysts predict that Cardinal Health, Inc. will post 7.82 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a $0.5056 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.65%. Cardinal Health’s dividend payout ratio is currently 39.30%.

Cardinal Health Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Further Reading

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.